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The manuscript describes the characterization of the interaction between meso-tetrakis(p-sulfonato-
phenyl)porphyrin (TSPP) and human serum albumin (HSA). TSPP is a candidate for the photosensitization
of structural and functional changes in proteins while HSA provides both an excellent protein model and
binding and functional characteristics that could be explored in future applications of the approach. A
combination of optical spectroscopic techniques (e.g., ﬂuorescence spectroscopy, ﬂuorescence lifetime,
circular dichroism, etc.) and computational docking simulations were applied to better characterize the
TSPP/HSA interaction. Recent advances have revealed that the complex formed by TSPP and HSA has
become potentially relevant to biomedical applications, biomaterials research and protein photo-
sensitized engineering. The study has determined a likely location of the binding site that places TSPP at
a site that overlaps partially with the low afﬁnity site of ibuprofen and places one of the −SO3 groups of
the ligand in proximity of the Trp214 residue in HSA. The characterization will enable future studies
aimed at photosensitizing non-native functions of HSA for biomedical and biomaterial applications.
& 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The importance of porphyrins in living organisms is under-
scored by their ubiquitous biochemical functions and by their
potential biomedical and biotechnological applications [1,2].
Heme, for instance, occupies a central role in a myriad of biological
functions [2]. The combination of the natural occurrence of many
porphyrin-like molecules and their photophysical properties (e.g.,
relatively large yields for intersystem crossing to the triplet state
or the potential for photoinduced electron transfer [3,4]) has cre-
ated widespread interest that includes basic photophysical and
photochemical characterizations [5], self-assembly [6,7], and bio-
medical applications such as their use as a photosensitizers in the
phototherapy and photodetection of cancer and other abnormal
tissues [8–10]. The nuance of the photosensitization of porphyrins
in biomedical applications has recently highlighted the role of the
direct interaction between porphyrins and protein targets [11].
Many naturally occurring porphyrins often present the signiﬁcant
challenge of poor aqueous solubility and their consequent ten-
dency to form a very polydispersed family of aggregates [13]an open access article under the C
San Antonio, Department of
rancaleon).which, despite having insigniﬁcant photochemical characteristics
[13], greatly affect the spectroscopic characterizations. A possible
circumvention of the problem is provided by cationic and anionic
porphyrins. These are not-naturally occurring, but provide the
advantage of easy solubility in aqueous solution. Among them is
the anionic tetra-meso-phenylsulfonato-porphyrin (TSPP). At lar-
ger concentrations (4104 M) and lower pH (o5) this porphyrin
is also characterized by interesting self-assembly properties
[12,14–16]. However at μM concentration and pH 45.5 TSPP is
substantially monomeric in aqueous solution [17]. Anionic (and
cationic) porphyrins are expected to interact with proteins
through different electrostatic mechanisms and are expected to
dock at different locations of the protein [15] compared to heme or
other hydrophobic tetrapyrroles.
As mentioned above, the focus of our research is to employ
photosensitizing ligands to mediate changes in the structure and
function of proteins. Our group has demonstrated that low-irra-
diance optical excitation of TSPP, non-covalently docked to proteins,
causes conformational changes of some polypeptide [12,16]. These
initial results prompted us to investigate the effects on proteins that
are more relevant to biophysical and biomedical applications. One of
these is represented by human serum albumin (HSA) which is the
major carrier of exogenous and endogenous products in the blood-
stream, including heme and other porphyrin products [18,19]. Its
hypothesized role in the elimination of heme products, led to theC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
S.C. Rozinek et al. / Biochemistry and Biophysics Reports 7 (2016) 295–302296discovery and characterization of a binding site for hemin (the Fe3þ
chelate of heme), as well as other tetrapyrroles [20,21] and has
produced much interest in the physiological and non-physiological
properties of heme-HSA complexes [22,23]. The heme binding
pocket has been experimentally identiﬁed in the primary cleft of
subdomain IB of HSA and is deﬁned by three basic residues at the
pocket entrance and a Tyr residue (Tyr161) which coordinates with
the metal at the center of the porphyrins ring [20]. In comparison
with heme and other protoporphyrins, the size and charges on TSPP
suggest potentially different mechanisms and sites of interaction.
We have therefore investigated the non-covalent docking of TSPP to
HSAwith the goal of estimating the location of its binding site. Since
this porphyrin has shown to be more effective at producing con-
formational changes of proteins [14,24], it holds the potential to
prompt photosensitized changes in a biomedically crucial protein
such as HSA. The possibility to trigger conformational changes using
the combination of laser irradiation of a porphyrin ligand, could
enable us to artiﬁcially enhance or modify the binding properties of
HSA. This could have repercussions in future developments of the
use of porphyrin/albumin complexes as an artiﬁcial enzyme [25], or
a substitute for hemoglobin or myoglobin [26].2. Materials and methods
2.1. Chemicals
Globulin-free HSA (A3782), warfarin (A2250), ibuprofen
(I4883) and hemin (51,280) were purchased from Sigma-Aldrich
(St. Louis, MO). Spectroscopic grade DMSO was also purchased
from Sigma-Aldrich (St. Louis, MO) while TSPP was obtained from
Frontier Scientiﬁc (Logan, UT). All chemicals were used without
further puriﬁcation.
2.2. Sample preparation
Concentrated stock solutions of the mono-dispersed TSSP were
prepared at least 24 h prior to the experiments by dissolving the
solid porphyrin in deionized water (DI). The stock solutions were
subsequently kept in the dark at room temperature and were
stable for up to two weeks. Before each experiment the stock so-
lution was diluted in phosphate buffer at physiological pH, to
obtain a ﬁnal porphyrin concentration in the 2–8 μM range. The
concentration was determined spectroscopically using the Beer-
Lambert relationship [27] ( ε=λ λOD cl) with ϵ413¼510,000 M1 cm1
for TSPP [28].
Stock solutions of HSA were prepared fresh before each ex-
periment by dissolving the lyophilized protein in phosphate buffer
at pH 7.4. Buffers were prepared at least 24 h in advance by dis-
solving a saline tablet (P4417, Sigma-Aldrich, St. Louis, MO) in
200 mL of DI water (Ω418 Ω). All buffers were kept at 6 °C, and
only the volume necessary for each experiment was withdrawn
and allowed to equilibrate at room temperature before the start of
the measurements. Buffers were discarded and made fresh every
7 days.
2.2.1. Instrumentation and methods
2.2.1.1. Steady state measurements. Absorption spectra were re-
corded using a dual beam Evolution 300 spectrophotometer
(Thermo Fisher Scientiﬁc, Waltham, MA) at 1.5 nm resolution and
240 nm/min sampling speed. Steady state ﬂuorescence spectra
were recorded with an Aminco Bowman-2 double mono-
chromator ﬂuorimeter (Thermo Fisher Scientiﬁc, Waltham, MA) at
1 nm/s with a 4 nm bandwidth in excitation and emission. All
spectra were corrected for the spectral response of the instrument
as well as absorption and inner ﬁlter effects (Eq. (2)a and b).Circular Dichroism spectra (CD) were recorded using a DSM 16
CD spectroplarimeter with a modiﬁed Cary 118 monochromator
(Olis Inc., Bogart, GA). The monochromator, lamp-housing and
sample-compartment were thoroughly purged with nitrogen gas
from a liquid-N2 tank prior to and during data acquisition. All
spectra were recorded in the Soret band region and blank
subtracted.
2.2.1.2. Time-resolved experiments. Fluorescence decay lifetimes
were measured using a time-correlated single photon counting
(TCSPC) instrument (Fluorocube, Horiba Scientiﬁc, Edison, NJ) with
a 294 nm pulsed LED (NanoLED-293, Horiba JobinYvon, Edison NJ)
source of 1 ns pulse width and 1 MHz repetition rate. Decays
were recorded at the emission maximum of HSA with a 12 nm
bandwidth.
2.2.1.3. Fluorescence quenching. Binding between porphyrins and
proteins can be investigated by recording the quenching of the
intrinsic ﬂuorescence of the protein as a function of the con-
centration of the porphyrins (i.e., quencher). From the analysis of
the quenching, one can extrapolate whether the mechanism is
collisional or static and in the second case establish the binding
constant [29]. Fluorescence quenching of HSA by TSPP was mea-
sured by recording the emission of the protein upon addition of
increasing aliquots of an aqueous stock of the porphyrin to the
solution containing HSA ( 4 μΜ). The concentration of TSPP is
determined from the value of its absorption maximum using the
molar extinction coefﬁcient reported above. Emission spectra of
HSA were recorded between 300 and 450 nm with λex¼295 nm
(where one can assume exclusive excitation of the lone Trp214
residue [30]). The selected protein concentration ensures an
OD295o0.1.
In order to distinguish between the contributions of dynamic
and static quenching, we examined the effect of temperature by
performing quenching experiments at 22 °C as well as 30 °C and
40 °C using aliquots of the same porphyrin and protein stocks.
Temperature was changed using a Peltier temperature control
element (SPG 1A, Thermo Fisher Scientiﬁc, Waltham, MA) in ab-
sorption, and a water circulator (Polystat, Cole Parmer, Vernon
Hills, Il) in ﬂuorescence. The setting in both devices were kept as
to ensure the same equilibration temperature in the two
instruments.
Throughout the sample preparation and measurement, the
lights in the laboratory were dimmed in order to ensure minimal
ambient light exposure of the sample (measured at  50 μW/cm2
in the areas where samples were handled) as to avoid photo-
chemical effects on the porphyrin and the protein [24].
2.2.1.4. Fluorescence quenching analysis. Fluorescence quenching
constants were calculated using the Stern-Volmer (S-V) Eq. (1)
[31].





where F is the total ﬂuorescence intensity of HSA and F0 indicates
the ﬂuorescence before addition of the quencher, KQ is the
quenching constant, and [Q] is the concentration of the porphyrin
determined spectrophotometrically as described above. KQ is ob-
tained from the slope of F
F
0 vs. [Q]. Additional information of the
quenching experiments are provided in the Supplementary
Material.
2.2.1.5. Porphyrin ﬂuorescence. In addition to probing the ﬂuores-
cence quenching of the protein, interactions of porphyrins with
proteins can be investigated by recording the changes in the
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of the polypeptide [28,32]. Such changes can be formalized and
quantiﬁed through the Benesi-Hildebrand model that can be
summarized by Eq. (2).




In this equation A and A0 represent the absorption of free and
docked TSPP (see below), respectively and ′A is the absorption
signal of the porphyrin extrapolated at inﬁnite protein con-
centration, [ ]HSA is the protein concentration (in molarity) and Kb
is the binding constant.
Additional details of the method are provided in the Supple-
mentary Material. In order to determine the binding of TSPP to
HSA, increasing aliquots of the albumin stock (40–60 μM, de-
termined spectrophotometrically using ϵ280¼35296 M1 cm1
[33]) were added to a diluted solution of the porphyrin buffer
stock. The absorption and emission spectra of TSPP were recorded
within 2–5 min after each addition (see below). Throughout the
experiment the OD of TSPP (free or bound to HSA) remained
o0.15 at the excitation wavelength (405 nm). Such OD ensures a
substantially uniform light distribution within the 1 cm optical
pathlength of the quartz cells and minimizes artifacts from inner
ﬁlter or other non-linear effects. The molar extinction coefﬁcient
of TSPP at the maximum of absorption (278 nm) and excitation
wavelength of the protein (294 nm) was estimated to be smaller
than the one of the protein (ϵ o 20,000 cm1 M1).
Typically Eq. (2) is applied using the ﬂuorescence of the ligand.
However, since the emission intensity of TSPP does not increase
with the addition of HSA, we used the absorption spectrum of the
porphyrin as a function of the protein to extrapolate the amount of
free and bound ligand as explained in the Supplementary Content.
2.2.1.6. Competitive binding: protocol. Competitive binding between
TSPP and well-characterized HSA ligands (i.e., warfarin, ibuprofen
and hemin) were carried out using both the ﬂuorescence of the
porphyrins (i.e., using the B-H method) and the quenching of HSA
emission (i.e., using the S-V method). Binding competition can be
used to establish whether TSPP competes for any of the docking
locations of warfarin, ibuprofen and hemin which have been thor-
oughly characterized [19,34–36]. For all competitive binding experi-
ments, HSA stocks were prepared dividing a large volume into
smaller volumes. Each smaller-volume was incubated with an excess
of competing ligand (3:1 warfarin/ibuprofen/hemin: HSA), while the
control volume contained no competing ligand. The concentrations
of the competitive ligands were determined spectrophotometrically
using ϵ308¼12500 M1 cm1 for warfarin, ϵ222¼9900 M1 cm1
for ibuprofen [37,38] and ϵ405¼40573 M1 cm1 for hemin (ﬁrst
dissolved in DMSO then added to buffer with ﬁnal aqueous DMSO
concentration under 2% by volume) derived by comparison with
identically concentrated solutions in DMSO where ϵ403
¼1.7105 M1 cm1 [39]. All competition experiments were car-
ried out at room temperature.
2.2.1.7. Competitive binding. HSA ﬂuorescence quenching. Quench-
ing experiments were performed by completing the same S-V
protocols described above. Aliquots of the concentrated porphyrin
stocks were added to the HSA or HSA/competing-ligand solutions
(described above). The emission of the protein (ex¼295 nm) was
recorded between 300 and 450 nm as a function of the total
porphyrin concentration.
2.2.1.8. Competitive binding. Benesi-Hildebrand method. Binding
experiments were completed with the procedure described earlier.
Aliquots of concentrated stocks of HSA, or HSA/competing-ligandwere added to aqueous porphyrin stocks. The region of the Soret
band of TSPP as a function of total protein concentration was re-
corded and the spectrum analyzed using the Gaussian ﬁtting de-
scribed in the Supplementary Content.
2.2.1.9. Analysis of ﬂuorescence decay. The DAS6.2 ﬂuorescence
decay analysis software (Horiba Scientiﬁc, Edison, NJ) yielded
ﬂuorescence lifetime values and their relative amplitudes (τi and
αi respectively) using re-convolution and least-square ﬁtting
methods under the assumption that the decay kinetics can be
represented by the equation







as extensively discussed in the literature (for example Ref. [31] and
citations within). The instrument response function needed for the
re-convolution algorithmwas collected using a 1 mg/mL scattering
solution of silica gel (Sigma Aldrich, H0761) in deionized water.
Fitting was performed with various numbers of exponential
components, and in all cases the best ﬁt with the fewest free
parameters was obtained using 3 exponentials, which is consistent
with previous results obtained from HSA in solution [40]. From the
values retrieved by the ﬁtting procedure, the average decay life-






2.2.1.10. Docking simulations-structure preparation. The Protein
Data Bank ﬁle ID 1O9X, which includes HSA complexed with tet-
radecanoic acid (myristic acid) and hemin [20], provided the initial
protein coordinates. Using ArgusLab 4.0.1 (Planaria Software,
Seattle, WA) hemin and all myristic acid coordinates were re-
moved and hydrogen atoms were added based on the hybridiza-
tion and bonding pattern of the heavy atoms. Kollman charges
were then added to the protein using AutoDock Tools 1.5.4 [41].
Initial coordinates for hemin were directly isolated from 1O9X and
hydrogen atoms were added using ArgusLab. TSPP was created
using Spartan 10 (Wavefunction Inc., Irvine, CA). Gasteiger partial
charges were assigned to the porphyrin, and all non-polar hy-
drogen atoms were merged (i.e., deleted with their charges added
to their closest bonded non-hydrogen atom) in AutoDock Tools.
2.2.1.11. Docking simulations-docking procedure. Binding of TSPP to
HSA was simulated using AutoDock 4.2 [42] following a procedure
described in details elsewhere [43]. Coarse sampling was initially
performed to survey the region(s) of the protein that yielded the
most energetically favorable binding areas. Coarse sampling was
run with larger grid spacing of.375 Å and one order of magnitude
fewer maximum number of evaluations (2.5106 energy evalua-
tions). Reﬁned runs were then carried out at the locations that
returned the best energy conformations, by using a smaller grid
spacing (see below) and a larger maximum number of evaluations
in the genetic algorithm. All rotatable bonds of the ligand were
allowed to rotate during the docking simulation while the struc-
ture of HSA was held rigid. Grid maps were generated through the
program AutoGrid which recalculates atomic afﬁnity, electrostatic,
and desolvation potentials for each atom type in the ligand mo-
lecule being docked. The energy of interaction of each ligand atom
with the protein is assigned to a point in a grid box which was
typically set at 126126126 Å, except for the binding of PPIX at
the cleft-site where the grid box was 110110110 Å. In the re-
ﬁned docking simulations the grid points were separated by
0.186 Å. AutoGrid uses the distance-dependent dielectric of Meh-
ler and Solmajer [44]. The standard docking protocol for rigid and
Table 1
Static quenching constants (KSV) retrieved from Eq. (1). Binding constants (Kb)
extrapolated from the Benesi-Hildebrand plots retrieved from the ﬂuorescence of
the porphyrin upon addition of HSA.
T KSV (M1) Kb (M1)
22 °C 99.3104 2.8105
22 °C þ ibuprofen 85.2104 No apparent binding
30 °C 87.6104
40 °C 78.3104
S.C. Rozinek et al. / Biochemistry and Biophysics Reports 7 (2016) 295–302298ﬂexible ligand docking consisted of 10 independent runs per li-
gand, using a population of 150 randomly placed individuals, with
2.5107 energy evaluations, a maximum number of 2.5106
generations, a mutation rate of 0.02, a crossover rate of 0.80, and
an elitism value of 1. The probability of performing a local search
on an individual in the population was 0.06, using a maximum of
300 iterations per local search. During the AutoDock calculation,
the energy of a particular conﬁguration is evaluated from the va-
lues of the grid using the Lamarckian genetic algorithm for mini-
mization with default parameters that include random starting
positions, orientations, and torsions that were generated before
each run. The most likely docked conﬁguration was retrieved from
the binding energy which is derived from the grid score and the
internal energy value of the ligand (which accounts for the energy
penalty of distorting the molecule).3. Results and discussion
3.1. Binding
Experiments were carried out to investigate the formation of
the non-covalent complex between TSPP and the native form
(N) of HSA [45]. In comparison to earlier studies [28] the current
investigation places an emphasis on the interaction mechanisms
and the location of the docking site which were not characterized
previously.
3.1.1. TSPP ﬂuorescence
The addition of HSA causes the broadening and the shift of the
absorption peak of TSPP from 413 nm to 420 nm accompanied by a
decrease in intensity (Fig. S1). The same addition causes the
ﬂuorescence peaks to shift from 643 nm and 699 nm to 648 nm
and 713 nm, respectively (Fig. S4, Supplementary Content). These
features are consistent with the binding of TSPP to proteins
[14,28]. Unlike the emission of hydrophobic porphyrins [46], the
shift in ﬂuorescence is not accompanied by a substantial increase
of the intensity. Therefore, one cannot construct B-H plots from
the emission spectra of TSPP and an alternative method must be
used. One such method employs the Gaussian ﬁtting of the Soret
band region in the absorption spectra as described in the “Methods
Section” (Fig. S3, Supplementary Content). The data from the ﬁt-
ting yield a linear B-H plot with a Kb¼2.8105 M1 (Fig. 1 and
Table 1).Fig. 1. Benesi-Hildebrand plot of TSPP binding afﬁnity to HSA (▲).3.1.2. Competitive binding
The presence of ibuprofen bound to HSA prevents TSPP from
docking to HSA as shown by the absence of the red-shift of the
absorption maximum of the porphyrin as a function of increasing
HSA/ibuprofen complex (Fig. 2A). Binding competition with war-
farin and hemin could not yield quantitative results from B-H
plots. These competing ligands present photophysical character-
istics that interfere with the optical measurements needed to in-
vestigate competition with porphyrins. Hemin has a strong
quenching effect on TSPP in addition to a substantial overlap in the
absorption spectrum. Warfarin also absorbs and emits in a region
that interferes with the measurements, thus preventing the cal-
culation of quantitative results. Qualitatively, however, the ex-
periments established (Fig. 2B and C) that TSPP is still able to dock
to HSA in the presence of either competing ligands, because the
spectrum of the porphyrin shows a shift to longer wavelength
consistent with binding to the protein.
3.1.3. HSA ﬂuorescence quenching
Adding TSPP to HSA (4 μM solution) causes the ﬂuorescence
intensity of the protein to decrease without peak shift (Fig. S2,
Supplementary Content). This is consistent with the fact that HSA
has a single Trp residue, thus, its quenching cannot lead to a shift
in emission because there are no other non-quenched residues
that can contribute to the ﬂuorescence. S-V plots (Fig. 3A) provide
KQ¼9.9105 M1. S-V plots can be ambiguous since a linear
trend is common to both collisional and static quenching. How-
ever, the two mechanisms describe different physical situations
and yield a different meaning of the quenching constant [31]. One
approach that can distinguish static and collisional mechanisms
employs the temperature dependence of the quenching constant.
Raising the temperature tends to dissociate a non-covalent ligand-
protein complex, therefore decreases the static quenching con-
stant. Conversely, higher temperature, increases the dynamic
quenching constant, due to a larger frequency of thermally-driven
collisions [29]. The data show that KQ decreases with increasing
temperature (Fig. 3A, Table 1) which is consistent with static
quenching due to the formation of the TSPP/HSA complex. Static
quenching can be conﬁrmed also theoretically. In fact from
τ=K kQ q 0 [31] one retrieves a value of the bimolecular quenching
rate ~ ∙ − −k M s2 10q 14 1 1 assuming τ0 as the average ﬂuorescence
lifetime of HSA without TSPP (Table 2). The value of kq is related to
the diffusion coefﬁcients DQ and DT of the quencher and the
chromophore (HSA in this case) through [31].
= ( )k f k 5q Q 0
where
( )( )γ= + + ( )k D D R R 6HSA TSPP HSA TSPP0
In this last relation γ  ∙8 1021 [31], while RT and RQ are the
radii of the protein and the quencher respectively. From the size of
HSA and TSPP [47] ( )+R RHSA Q  RHSA  ∙ −3.5 10 9m [48] and from
the diffusion coefﬁcients at room temperature for the two
Fig. 2. (A) Absorption of TSPP as a function of increasing concentration of HSA/ibuprofen complex. (B) Absorption of TSPP as a function of increasing concentration of HSA/
warfarin complex. (C) Absorption of TSPP as a function of increasing concentration of HSA/hemin complex. In each ﬁgure the arrow indicates the direction of the spectral
changes with increasing protein concentration. The initial and ﬁnal concentrations are also indicated next to the arrow.
Fig. 3. (A) Temperature dependent Stern-Volmer plots of HSA ﬂuorescence quenched by TSPP at 22 °C (△, —), 30 °C (, ― ―), and 40 °C (▽, ‑ ‑).(B) Fluorescence quenching by
porphyrin in the absence and presence of competing ibuprofen. Quenching of HSA by TSPP (▲,—); quenching of HSA/ibuprofen complex by TSPP (△,― ―).The solid lines
represent the linear regression of the individual plots.
S.C. Rozinek et al. / Biochemistry and Biophysics Reports 7 (2016) 295–302 299molecules ( )+D DHSA Q  ~ ∙ −D 1 10Q 9 m2s1 [49,50] one estimates a
value kq ∙ − −M s3 104 1 1 which is 10 orders of magnitude smaller
than the one obtained from our experiments. The estimated value
of kq would actually be even smaller since the one we calculated
considers a quenching efﬁciency, fQ¼1. Therefore collisional
quenching between TSPP and HSA can be conﬁdently ruled outand Eq. (2) yields KQ ¼ Kb¼9.9105 M1 which is in agreement
with the binding of porphyrins to proteins [28].
3.1.4. Fluorescence lifetime
Finally, the ﬂuorescence decay of HSA as a function of added
TSPP conﬁrms the static mechanism. As shown in Fig. 4, addition
Table 2
Fluorescence lifetimes before and after irradiation in air and deoxygenated samples.
Sample (conditions) Laser dose Fluorescence decay parameters Average lifetime
HSA J/cm2 τ1 (ns) A1 (%) τ2 (ns) A1 (%) τ3 (ns) A1 (%) oτ4
Air 0 6.20 47.73 2.59 41.89 0.41 10.68 4.09
TSPP/HSA J/cm2 τ1 (ns) A1 (%) τ2 (ns) A1 (%) τ3 (ns) A1 (%) oτ4
Air 0 6.25 43.70 2.16 39.25 0.28 17.04 3.63
44 6.32 38.44 2.06 38.74 0.22 22.82 3.02
Deoxygenated 0 6.03 38.35 1.85 36.07 0.16 25.58 3.02
44 6.48 32.21 2.03 34.25 0.17 33.54 2.84
Fig. 4. Fluorescence decay of HSA in the absence of TSPP (black line) and in the
presence of 3 μM TSPP (gray line).
Fig. 5. CD spectra of free (solid lines) and HSA-docked (dotted lines) PPIX (gray)
and TSPP (black) in the region of the Soret band.
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protein in the same samples where there is instead a large
quenching of the emission intensity. This evidence conﬁrms that
TSPP, under the conditions of our experiments, does not cause
collisional quenching. In addition the nearly constant ﬂuorescence
decay of HSA in the presence of TSPP also rules out the occurrence
of ﬂuorescence resonance energy transfer (FRET) between Trp214
and bound TSPP despite the overlap between the emission of the
aromatic residue and the Soret band of the porphyrin. The absence
of FRET indicates that the quenching of Trp214 might be caused by
the proximity of one of the −SO3 groups to the indole of the Trp
residue, rather than the stacking of the porphyrin macrocycle
(where the Soret band transition is localized [51]).
Thus, demonstrated that the origin of the quenching mechan-
ism is static, the value of KSV reduces to the one of Kb [31] and the
discrepancy between the magnitude of the binding constant ob-
tained through the B-H method and the one retrieved via the S-V
plots must be explained. The value of Kb retrieved through
quenching is consistent (actually identical within the experimental
error) to the one reported by another group [28]. Thus we are
inclined to believe that the value obtained from the B-H plot is
underestimated. The reason for underestimating Kb may be due to
the methodology used. Since we retrieved the amount of free and
bound TSPP from Gaussian ﬁtting of overlapping spectra the cross-
correlation of the ﬁtting parameters is likely to be large as to affect
the ratio of the areas of the free and bound TSPP to the overall area
of the Soret band.
Competition studies show that the quenching constant is re-
duced by the presence of ibuprofen, while quenching competition
with warfarin and hemin did not provide reliable results for the
reasons explained earlier.3.1.5. Circular dichroism
Interesting is the dichroic activity of TSPP bound to HSA. The
dichroic signal shows a week negative Cotton effect [52], with a
trough at 411 nm, for the free form of TSPP (Fig. 5). However,
binding to HSA prompts a peak shift (to 418 nm) and an increase in
the intensity of the negative Cotton effect (Fig. 5). Fig. 5 therefore
suggests that binding increases the distortion of TSPP [53] through
interactions with amino acid side chains [52].
3.2. Docking simulations
A coarse sampling across the entire HSA molecule, resulted in
many possible binding locations with binding energies that are in
the order of 5.0 kcal/mol. Based on the binding competition
between TSPP and ibuprofen (Fig. 3B), reﬁned searches were
completed in and around the two main binding sites of the drug
which, according to x-ray diffraction results, are located in sub-
domain IIIA (higher afﬁnity) and between subdomain IIA and IIB
(lower afﬁnity) [19]. The search yielded a viable docked con-
formation of TSPP near the location of the lower afﬁnity binding
site for ibuprofen (Fig. 6A). Though the lowest free energy of
binding is only 4.15 kcal/mol at this location, each negatively
charged sulfonic group of TSPP appears to interact with one or
more positively charged Lys or Arg residues located between 5 Å
(Lys 475, Lys 205, Arg 209) and 11 Å (Lys 351 and Arg 348). Closer
inspection shows that at this location the “penalty” for the tor-
sional energy of the porphyrin is large and positive (þ3.58 kcal/
mol) and causes an overall less favorable energy minimum than
would be expected from the electrostatic interactions alone. Such
“penalty” would be consistent with the Cotton effect observed in
CD. The energy “penalty” in the docking simulations is created by
the fact that the protein is considered rigid and the ligand has
limited ﬂexibility. Therefore the energy penalty is an indication of
strain on the structure of the ligand (i.e., a positive contribution to
Fig. 6. (A) Docking simulation results for PPIX in the central cleft of HSA. The ﬁgure shows the remaining proximity with the Arg114 residue already participating in the
binding to the heme pocket. (B) Docking simulation results for TSPP near the ibuprofen binding site. The ﬁgure shows the proximity of the 4 negatively charged sulfonic
groups of the porphyrin with the positively charged Lys and Arg residues. (C) Overall view of HSA with docked PPIX (blue) and TSPP (red) and the crystal structure heme
(yellow) at the sites shown in part A and B. The ﬁgure shows the position of each porphyrin relative to the lone Trp214 residue.
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ligand and atoms of the protein, that cannot be compensated by
their structural modiﬁcations (e.g., rotation of bonds). However
the actual docked TSPP would not have the constrained posed by
the computational model and in the presence of steric clashes it
could modify its structure. If the steric hindrance is at the mac-
rocycle it may prompt it to “deform” out of plane, thus causing a
change of symmetry of the porphyrin ring [54,55] that may ori-
ginate the Cotton effect. Additionally, this binding location places
TSPP in close proximity to several aromatic residues which is also
in agreement with the spectroscopic ﬁndings [53]. As discussed
earlier, TSPP causes highly efﬁcient quenching of the ﬂuorescence
of the lone Trp214 residue of HSA (Table 1). The binding location of
Fig. 6B places one of the S atoms of TSPP 12 Å from Trp 214. This
distance is approximately half the distance to the site of the heme
(Fig. 6B) [20]. Sulfur atoms are efﬁcient ﬂuorescence quenchers
[56,57] and the presence of the −SO3 in proximity to Trp214 is in
agreement with the static quenching of the aromatic residue.4. Conclusions
The binding of TSPP to HSAwas ﬁrst demonstrated over a decade
ago [28] however the mechanisms of the binding or the possible
location of the docking site was not established. The work presented
here conﬁrms the formation of a ground-state TSPP/HSA complex
and validates the binding constant observed previously (106 M1)
[28]. Our results however shed additional light on the location of the
binding and the nature of the interaction. The combination of
spectroscopic data and docking simulation converge into a model
that establishes that TSPP docks HSA at a location that overlaps with
the region of the low afﬁnity site for ibuprofen and is consistent not
only with the quenching of the Trp214 residue but also with the
induced negative Cotton effect detected with CD spectroscopy. The
lack of FRET indicates that the conformation of TSPP places one of
the −SO3 groups of the porphyrin in proximity of Trp214 instead of
the porphyrin macrocycle. However, the presence of the group of
aromatic amino acids (e.g., Phe206) near the macrocycle could
prompt the negative Cotton effect. These amino acids would likely
force the porphyrin ring to deform, thus relaxing the energetic pe-
nalties recorded in the docking simulations. The results we obtained
are important to undergoing studies to determine the photo-
sensitization of conformational changes in HSA as they allow us to
more precisely investigating the possible conformational changes
and correlate them with functional changes of the protein.Acknowledgments
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